This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Discoverrx Corporation, Irhythm Technologies, Inc.. Active years: 2014-2026.
Company Filing History:
Years Active: 2014-2026
Title: Evangelos Hytopoulos: Innovator in Restenosis Prevention
Introduction
Evangelos Hytopoulos is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of medical technology, particularly in the prevention of restenosis. His innovative work has led to the development of methods that can potentially improve patient outcomes in cardiovascular treatments.
Latest Patents
Hytopoulos holds 1 patent for his invention titled "Methods for identifying agents and their use for the prevention of restenosis." This patent focuses on identifying agents that inhibit or prevent restenosis by assaying test agents in a series of assays. These assays measure the effects of the test agents on cell proliferation, thrombosis, tissue modeling, and inflammation. The treatment for restenosis is provided using compositions derived from this invention.
Career Highlights
Evangelos Hytopoulos is associated with DiscoverRx Corporation, where he applies his expertise in developing innovative solutions for medical challenges. His work has been instrumental in advancing the understanding of restenosis and its prevention.
Collaborations
Hytopoulos has collaborated with notable professionals in his field, including Eric J Kunkel and Ivan Plavec. These collaborations have further enriched his research and development efforts.
Conclusion
Evangelos Hytopoulos is a distinguished inventor whose work in the prevention of restenosis showcases his commitment to improving healthcare outcomes. His innovative methods and collaborations highlight the importance of research in medical technology.